
Partner: Instance Ltd
Scientific progress, changing demographics and innovation in healthcare are bringing new attention to the longevity economy.
At UKFOS Oxford 2026, a dedicated Main Stage panel will examine the opportunities and challenges associated with investing in healthcare, biotechnology, preventive medicine and healthy ageing. The session, The Longevity Economy: Investing in Healthcare, Biotech & Healthy Ageing, will bring together perspectives from family capital, life sciences, healthcare and investment.
Understanding the longevity investment landscape
Longevity encompasses a broad range of activities, from established healthcare services and medical technologies to emerging biotechnology and scientific research. These areas differ significantly in their development timelines, capital requirements, regulatory exposure and commercial maturity.
For long-term investors, understanding these differences is essential. The panel will examine how investors can distinguish established commercial opportunities from technologies and business models that remain at earlier stages of development.
The importance of scientific and commercial evidence
Healthcare investment requires careful consideration of clinical evidence, regulatory pathways, market demand and the practical challenges of bringing new technologies to market. Promising scientific developments do not automatically translate into successful businesses.
Oxfordshire’s life sciences ecosystem
Oxfordshire provides a relevant setting for this discussion through its universities, research institutions and wider innovation environment. The panel will consider what research and innovation clusters can tell investors about the development of healthcare businesses and the infrastructure needed to support them.
Meet the panel
Moderator: Rosemary Sinclair Dokos — NucleicAI.
Panellists: Neetu Puranikmath — Single Family Office; Dr Jed Lye — Instance Ltd; Richard G.A. Faragher — University of Brighton; Mila Morris — Nova Arc Health.

Rosemary Sinclair Dokos
Chief Commercial and Product Officer, NucleicAI

Neetu Puranikmath
Senior Investment Officer – Venture, Single Family Office

Dr Jed Lye
Founder CEO, Instance Ltd

Richard G.A. Faragher
Professor of Biogerontology, University of Brighton

Mila Morris
Founder & CEO, Nova Arc Health
Session: The Longevity Economy: Investing in Healthcare, Biotech & Healthy Ageing. Session Partner: Instance Ltd.
UK Family Office Summit Oxford 2026 is fully booked. The next Oxford Summit takes place on 23–24 November 2027. Explore upcoming UKFOS events.
Session Partner
